Altman Peter's Form 4/A amendment
AmendedBioCardia, Inc. (BCDA) · filed Aug 18, 2023
- Accession no.
- 0001437749-23-024140
- Filed
- Aug 18, 2023
- Trade date
- Aug 14, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Aug 14, 2023
This filing lists 1 non-derivative transaction. Open-market purchases total $3.96K. It was filed 4 days after the trade.
This amendment replaces 0001437749-23-023755 (filed Aug 14, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Altman PeterCIK 0001647542 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2023 | Common Stock | PPurchaseAcquired | +4,500 | $0.88 | +$3,960 | 443,339 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades ranging from $0.883 to $0.884 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.